SMPD1 and depressive symptom measurement: Additional evidence for the role of sphingolipids in the pathogenesis of depression is mostly based on alterations of ceramide or sphingomyelin species in human blood [21,22] or animal tissues [24,25], suggesting an involvement of acid sphingomyelinase as an enzyme hydrolyzing sphingomyelin to ceramide.